Apyx Medical Corporation to Participate in the Colliers Securities 2021 Institutional Investor Conference

Rhea-AI Summary

Apyx Medical Corporation (NASDAQ:APYX), a leader in advanced energy technologies, will participate in the Colliers Securities 2021 Institutional Investor Conference on September 9th, 2021. The event will be held virtually with management engaging in one-on-one meetings. Apyx is recognized for its innovative Helium Plasma Technology, marketed as Renuvion® in cosmetic surgery and J-Plasma® in the surgical market. These technologies enable precise tissue heating for enhanced surgical outcomes. For more details, visit www.ApyxMedical.com.

CLEARWATER, Fla.--(BUSINESS WIRE)-- Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, announced today that management will participate in the Colliers Securities 2021 Institutional Investor Conference, which is being held virtually on Thursday, September 9th. Management will participate in 1x1 meetings. There will be no formal presentation.

About Apyx Medical Corporation:

Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people’s lives through innovative products in the cosmetic and surgical markets. Known for its innovative Helium Plasma Technology, Apyx is solely focused on bringing transformative solutions to the physicians and patients it serves. The company’s Helium Plasma Technology is marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Renuvion® offers surgeons and physicians a unique ability to provide controlled heat to the tissue to achieve their desired results. The J-Plasma® system allows surgeons to operate with a high level of precision while minimizing unintended tissue trauma. The Company also leverages its deep expertise and decades of experience in unique waveforms through original equipment manufacturing (OEM) agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Apyx Medical Corporation website at www.ApyxMedical.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210901005897/en/

Investor Relations Contact:

Westwicke on behalf of Apyx Medical Corporation

Mike Piccinino, CFA

investor.relations@apyxmedical.com

Source: Apyx Medical Corporation

FAQ

When will Apyx Medical Corporation participate in the 2021 Institutional Investor Conference?

Apyx Medical Corporation will participate in the 2021 Institutional Investor Conference on September 9th, 2021.

What technologies does Apyx Medical Corporation offer?

Apyx Medical Corporation offers Helium Plasma Technology, marketed as Renuvion® for cosmetic surgery and J-Plasma® for surgical applications.

What is the focus of Apyx Medical Corporation?

Apyx Medical Corporation focuses on advanced energy technologies to improve surgical and cosmetic procedures.

What type of meetings will Apyx Medical Corporation hold during the conference?

During the conference, Apyx Medical Corporation's management will hold one-on-one meetings.

Where can I find more information about Apyx Medical Corporation?

More information about Apyx Medical Corporation can be found on their website at www.ApyxMedical.com.